ESR1 and breast cancer: In breast cancer, CAF-derived circulating EVs containing the full mitochondrial genome promote estrogen receptor (ER)-independent OXPHOS, inducing therapy-induced dormant cancer stem-like cells and leading to endocrine therapy resistance [167].